Joy W Chang
Overview
Explore the profile of Joy W Chang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
308
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chang J, LaFata S, Gee T, Redd W, Barlowe T, Cotton C, et al.
Dig Dis Sci
. 2024 Dec;
70(1):292-297.
PMID: 39641895
Background: Predicting fibrostenotic complications prior to endoscopy in eosinophilic esophagitis (EoE) is challenging and esophageal strictures and narrowing are commonly missed on endoscopy. Aim: To develop and validate a score...
2.
Chang J, Brophy K, Ryan K, Rubenstein J, Dellon E, Wallner L, et al.
Am J Gastroenterol
. 2024 Oct;
120(1):173-181.
PMID: 39422324
Introduction: Little is known about how patients make decisions about and prioritize therapies and disease management in eosinophilic esophagitis (EoE). We aimed to systematically identify and characterize patient perspectives and...
3.
Russin M, Chen J, Rubenstein J, Chang J
Am J Gastroenterol
. 2024 Oct;
120(3):663-666.
PMID: 39422172
Introduction: Dupilumab, the first US Food and Drug Administration-approved treatment for eosinophilic esophagitis (EoE), lacks real-world data on use and effectiveness. Methods: We conducted a retrospective cohort study of 70...
4.
Chang J, Dellon E, Mukkada V
Am J Gastroenterol
. 2024 Sep;
120(1):16-19.
PMID: 39311427
No abstract available.
5.
Wright B, Abonia J, Abud E, Aceves S, Ackerman S, Braskett M, et al.
J Allergy Clin Immunol
. 2024 Aug;
154(4):882-892.
PMID: 39111348
The Consortium of Eosinophilic Gastrointestinal disease Researchers (CEGIR) and The International Gastrointestinal Eosinophil Researchers (TIGERs) organized a daylong symposium at the 2024 annual meeting of the American Academy of Allergy,...
6.
Pyne A, Uchida A, Hazel M, Stubben C, Chang J, Bailey D, et al.
Dis Esophagus
. 2024 Jul;
38(1.
PMID: 38986036
A preliminary report from the recent phase 3 trial of benralizumab, a monoclonal antibody that binds to interleukin-5 receptor alpha (IL5Rα), in patients with EoE revealed that medication use led...
7.
Chang J, Jensen E
Immunol Allergy Clin North Am
. 2024 Apr;
44(2):145-155.
PMID: 38575214
Despite the rising prevalence and incidence of eosinophilic esophagitis (EoE), the etiology and pathophysiology remain unknown. Studies to date suggest that complex interactions between genetic and environmental risk factors result...
8.
Ketchem C, Lynch K, Chang J, Dellon E
Clin Gastroenterol Hepatol
. 2023 Oct;
22(5):1133-1135.
PMID: 37879522
No abstract available.
9.
Cohen-Mekelburg S, Jordan A, Kenney B, Burgess H, Chang J, Hu H, et al.
Clin Gastroenterol Hepatol
. 2023 Sep;
22(3):621-629.e2.
PMID: 37689253
Background & Aims: Current approaches to managing digestive disease in older adults fail to consider the psychosocial factors contributing to a person's health. We aimed to compare the frequency of...
10.
Rubenstein J, Fontaine S, MacDonald P, Burns J, Evans R, Arasim M, et al.
Gastroenterology
. 2023 Aug;
165(6):1420-1429.e10.
PMID: 37597631
Background & Aims: Tools that can automatically predict incident esophageal adenocarcinoma (EAC) and gastric cardia adenocarcinoma (GCA) using electronic health records to guide screening decisions are needed. Methods: The Veterans...